The NTCA Health Committee has provided the following update:
Dear NTCA Members,
You might be interested in this recent Canine Chronicle article summarizing a CHF study examining the potential benefit of MCT Oil in managing canine idiopathic epilepsy.
Dr. Holger Andreas Volk (Royal Veterinary College, University of London) studied the effects of a dietary supplement medium chain triglyceride (MCT) Oil in a clinical trial of 28 dogs. Dogs were randomly assigned to two groups and fed either MCT oil supplement or a placebo oil for 3 months. Then, after a washout period, the MCT intervention and placebo groups switched, and the study continued for 3 months (crossover design). The dogs continued their regular anti-seizure medications and regular diet during the study. The study found that both seizure frequency and severity of seizures were reduced, as well as improvement in medication side effects and quality of life while the dogs received MCT oil.
Here’s the link to Canine Chronicle article, posted by Sharon Albright DVM, Manager of Communications & Veterinary Outreach, AKC Canine Health Foundation.
NTCA Health Committee